Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T16:59:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays revision: v3.4.3 in place of the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:20.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied to the site, and the previous notice about government funding operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:30:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a site-wide funding-status notice and updated the page revision to v3.4.1; no study content or data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:24:35.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while adjusting older wording like 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. These are minor UI/metadata changes that do not affect core study information or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:16:53.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, with no observable changes to study content, eligibility criteria, or outcomes. No core study information was modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:14:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.